124 related articles for article (PubMed ID: 29547931)
1. Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers.
Kim SJ; Huzarski T; Gronwald J; Singer CF; Møller P; Lynch HT; Armel S; Karlan BY; Foulkes WD; Neuhausen SL; Senter L; Eisen A; Eng C; Panchal S; Pal T; Olopade O; Zakalik D; Lubinski J; Narod SA; Kotsopoulos J;
Int J Epidemiol; 2018 Jun; 47(3):987-997. PubMed ID: 29547931
[TBL] [Abstract][Full Text] [Related]
2. Weight Gain and the Risk of Ovarian Cancer in
Kim SJ; Lubinski J; Huzarski T; Møller P; Armel S; Karlan BY; Senter L; Eisen A; Foulkes WD; Singer CF; Tung N; Bordeleau L; Neuhausen SL; Olopade OI; Eng C; Weitzel JN; Fruscio R; Narod SA; Kotsopoulos J;
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2038-2043. PubMed ID: 34426412
[TBL] [Abstract][Full Text] [Related]
3. Body weight and risk of breast cancer in BRCA1/2 mutation carriers.
Manders P; Pijpe A; Hooning MJ; Kluijt I; Vasen HF; Hoogerbrugge N; van Asperen CJ; Meijers-Heijboer H; Ausems MG; van Os TA; Gomez-Garcia EB; Brohet RM; ; van Leeuwen FE; Rookus MA
Breast Cancer Res Treat; 2011 Feb; 126(1):193-202. PubMed ID: 20730487
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
[TBL] [Abstract][Full Text] [Related]
5. Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Lubinski J; Lynch HT; Tung N; Armel S; Senter L; Singer CF; Fruscio R; Couch F; Weitzel JN; Karlan B; Foulkes WD; Moller P; Eisen A; Ainsworth P; Neuhausen SL; Olopade O; Sun P; Gronwald J; Narod SA;
Breast Cancer Res Treat; 2019 Jun; 175(2):443-449. PubMed ID: 30756284
[TBL] [Abstract][Full Text] [Related]
6. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
7. Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Odén L; Akbari M; Zaman T; Singer CF; Sun P; Narod SA; Salmena L; Kotsopoulos J
Oncotarget; 2016 Dec; 7(52):86687-86694. PubMed ID: 27893411
[TBL] [Abstract][Full Text] [Related]
8. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
9. The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
Oh M; Alkhushaym N; Fallatah S; Althagafi A; Aljadeed R; Alsowaida Y; Jeter J; Martin JR; Babiker HM; McBride A; Abraham I
Prostate; 2019 Jun; 79(8):880-895. PubMed ID: 30900310
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.
Rennert G; Bisland-Naggan S; Barnett-Griness O; Bar-Joseph N; Zhang S; Rennert HS; Narod SA
N Engl J Med; 2007 Jul; 357(2):115-23. PubMed ID: 17625123
[TBL] [Abstract][Full Text] [Related]
11. Plasma RANKL levels are not associated with breast cancer risk in
Zaman T; Sun P; Narod SA; Salmena L; Kotsopoulos J
Oncotarget; 2019 Mar; 10(25):2475-2483. PubMed ID: 31069010
[TBL] [Abstract][Full Text] [Related]
12. Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Lammert J; Lubinski J; Gronwald J; Huzarski T; Armel S; Eisen A; Meschino WS; Lynch HT; Snyder C; Eng C; Olopade OI; Ginsburg O; Foulkes WD; Elser C; Cohen SA; Kiechle M; Narod SA; Kotsopoulos J
Breast Cancer Res Treat; 2018 Jun; 169(3):561-571. PubMed ID: 29404807
[TBL] [Abstract][Full Text] [Related]
13. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
14. Reproductive factors as risk modifiers of breast cancer in
Park B; Hopper JL; Win AK; Dowty JG; Sung HK; Ahn C; Kim SW; Lee MH; Lee J; Lee JW; Kang E; Yu JH; Kim KS; Moon BI; Han W; Noh DY; Park SK;
Oncotarget; 2017 Nov; 8(60):102110-102118. PubMed ID: 29254229
[TBL] [Abstract][Full Text] [Related]
15. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
[TBL] [Abstract][Full Text] [Related]
16. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Milne RL; Osorio A; Ramón y Cajal T; Baiget M; Lasa A; Diaz-Rubio E; de la Hoya M; Caldés T; Teulé A; Lázaro C; Blanco I; Balmaña J; Sánchez-Ollé G; Vega A; Blanco A; Chirivella I; Esteban Cardeñosa E; Durán M; Velasco E; Martínez de Dueñas E; Tejada MI; Miramar MD; Calvo MT; Guillén-Ponce C; Salazar R; San Román C; Urioste M; Benítez J
Breast Cancer Res Treat; 2010 Jan; 119(1):221-32. PubMed ID: 19370414
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case-control study.
Kim SJ; Zhang CXW; Demsky R; Armel S; Kim YI; Narod SA; Kotsopoulos J
Breast Cancer Res Treat; 2019 Apr; 174(3):741-748. PubMed ID: 30603998
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal study on the role of body size in premenopausal breast cancer.
Michels KB; Terry KL; Willett WC
Arch Intern Med; 2006 Nov; 166(21):2395-402. PubMed ID: 17130395
[TBL] [Abstract][Full Text] [Related]
19. Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians.
Nkondjock A; Robidoux A; Paredes Y; Narod SA; Ghadirian P
Breast Cancer Res Treat; 2006 Aug; 98(3):285-94. PubMed ID: 16541324
[TBL] [Abstract][Full Text] [Related]
20. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
Kotsopoulos J; Gronwald J; Karlan BY; Huzarski T; Tung N; Moller P; Armel S; Lynch HT; Senter L; Eisen A; Singer CF; Foulkes WD; Jacobson MR; Sun P; Lubinski J; Narod SA;
JAMA Oncol; 2018 Aug; 4(8):1059-1065. PubMed ID: 29710224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
